Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Acomplia treatment holds the key to the persistent fat problem

Released on = July 22, 2006, 1:10 am

Press Release Author = Lawrence Summers

Industry = Healthcare

Press Release Summary = The news of Acomplia getting approval for sale on
prescription in the UK spread like wildfire. The more joyous was the overwhelming
obese population, which got another ray of hope in their fight against fat. Acomplia
treatment, during trials has shown as much as four times weight loss as on a
placebo. Certainly, the Americans will have to wait until Acomplia gets the nod of
FDA- the agency in US that regulates food, dietary supplements and drugs in the US.
If the drug gets approval of FDA, it will be sold under the brand name Zimulti.

Press Release Body = The news of Acomplia getting approval for sale on prescription
in the UK spread like wildfire. The more joyous was the overwhelming obese
population, which got another ray of hope in their fight against fat. Acomplia
treatment, during trials has shown as much as four times weight loss as on a
placebo. Certainly, the Americans will have to wait until Acomplia gets the nod of
FDA- the agency in US that regulates food, dietary supplements and drugs in the US.
If the drug gets approval of FDA, it will be sold under the brand name Zimulti.

"Acomplia treatment is by far the most trustworthy way of combating obesity", so
says John Greene, a research scientist at Weight Loss Drug. Weight Loss Drug, which
is an online supplier of anti-obesity drugs of a large variety, claims that in
comparison to the other contemporary drugs in this segment, Acomplia fares better.
Acomplia treatment offers a fast reduction in fat and also side effects, as
witnessed with other drugs, are low.

So how does acomplia treat obesity? According to John Greene, "Acomplia is the brand
name of Rimonabant. The French pharmaceutical company Sanofi-Synthelabo has made a
breakthrough product by launching this drug. Acomplia blocks a cellular receptor in
the brain and thus influences the pleasure sensations that one gets out of eating.
In this manner, the appetite is dampened. Thus, acomplia reduces weight in a very
natural manner."

Weight Loss Drug has been flooded with orders for Acomplia. To learn more about
acomplia treatment and numerous other weight loss drugs like Didrex, Phentermine,
Xenical, Ionamin, etc. logon to www.weight-loss-drug.co.uk.


Web Site = http://www.weight-loss-drug.co.uk/rimonabant_acomplia.html

Contact Details = Lawrence Summers
New London State
CT County: New London Count
Email-lawrence_summers@hotmail.co.uk

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •